Ligand profile
HE8
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_02722 — Agmatinase
Identifiers
Database identifiers and provenance.
- Ligand ID
HE8- PDB
6q37- UniProt (similar protein)
P78540- Target protein
- KP13_02722
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 136.0
- −1 ≤ LogP ≤ 5 -2.32
- MW ≤ 500 Da 233.1
- LogP ≤ 5 -2.32
- H-bond donors ≤ 5 6
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 136.0
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
[B-](CCC[C@H]1CNC[C@]1(C(=O)O)N)(O)(O)O[B-](CCC[C@H]1CNC[C@]1(C(=O)O)N)(O)(O)O
InChI=1S/C8H18BN2O5/c10-8(7(12)13)5-11-4-6(8)2-1-3-9(14,15)16/h6,11,14-16H,1-5,10H2,(H,12,13)/q-1/t6-,8-/m0/s1InChI=1S/C8H18BN2O5/c10-8(7(12)13)5-11-4-6(8)2-1-3-9(14,15)16/h6,11,14-16H,1-5,10H2,(H,12,13)/q-1/t6-,8-/m0/s1
JNNZQSJBRFVUJB-XPUUQOCRSA-NJNNZQSJBRFVUJB-XPUUQOCRSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00491
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand HE8 →
- PDB RCSB structure 6q37 →
- UniProt UniProt P78540 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “HE8”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_02722.
PDB 11
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).